<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Stelara; Ustekinumab" /><meta name="IX" content="Stelara; Ustekinumab" /><title>Stelara®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP7790-stelara.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP7790-stelara.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP7790-stelara.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP7449-skin.htm">13 Skin</a> &gt; <a href="PHP7686-preparations-for-eczema-and-psoriasis.htm">13.5 Preparations for eczema and psoriasis</a> &gt; <a href="PHP7766-drugs-affecting-the-immune-response.htm">13.5.3 Drugs affecting the immune response</a> &gt; <a href="PHP7782-cytokine-modulators.htm">Cytokine modulators</a> &gt; <a href="PHP7789-ustekinumab.htm">USTEKINUMAB</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP7787-infliximab.htm" title="Previous: INFLIXIMAB">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP7791-acne-and-rosacea.htm" title="Next: 13.6 Acne and rosacea">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a311010.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ustekinumab</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Skin and Mucous Membrane Agents 84:00 &gt; Skin and Mucous Membrane Agents, Miscellaneous 84:92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/25217-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ustekinumab</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: U &gt; Interactions of Ustekinumab</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP7766-drugs-affecting-the-immune-response.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">13.5.3 Drugs affecting the immune response</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis</p></div></li><li><a href="PHP7789-ustekinumab.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">USTEKINUMAB</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 13 Skin &gt; 13.5 Preparations for eczema and psoriasis &gt; 13.5.3 Drugs affecting the immune response &gt; Cytokine modulators</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/25217-e.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ustekinumab</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Dermatological Drugs and Sunscreens &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/10357.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ustekinumab</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; U &gt; US</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-U8.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ustekinumab</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; U</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>USTEKINUMAB</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int1151-ustekinumab.htm">Ustekinumab</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see <a title="BNF:target-block: Cytokine modulators in psoriasis" href="PHP7766-drugs-affecting-the-immune-response.htm#PHP7769">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">predisposition to infection; history or development of malignancy; elderly; <strong>interactions</strong>: Appendix 1 (ustekinumab)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Tuberculosis</h3> <p class="cT">Patients should be evaluated for tuberculosis before treatment. Active tuberculosis should be treated with standard treatment (<a title="sub-section: Antituberculous drugs" href="PHP3588-antituberculosis-drugs.htm">section 5.1.9</a>) for at least 2 months before starting ustekinumab. Patients who have previously received adequate treatment for tuberculosis can start ustekinumab but should be monitored every 3 months for possible recurrence. In patients without active tuberculosis but who were previously not treated adequately, chemoprophylaxis should ideally be completed before starting ustekinumab. In patients at high risk of tuberculosis who cannot be assessed by tuberculin skin test, chemoprophylaxis can be given concurrently with ustekinumab. Patients should be advised to seek medical attention if symptoms suggestive of tuberculosis (e.g. persistent cough, weight loss, and fever) develop</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">active infection</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid; manufacturer advises effective contraception during treatment and for 15 weeks after stopping treatment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid—present in milk in <em>animal</em> studies</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">infections (sometimes severe); diarrhoea; hypersensitivity reactions (possibly delayed onset), pain in pharynx and larynx; headache, fatigue, dizziness, depression; arthralgia; myalgia; nasal congestion; pruritus, injection-site reactions</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p><span class="cK">By subcutaneous injection</span>, plaque psoriasis, <span class="cP">adult</span> over 18 years, body-weight under 100 kg, initially 45 mg, then 45 mg 4 weeks after initial dose, then 45 mg every 12 weeks; body-weight over 100 kg, initially 45–90 mg, then 45–90 mg 4 weeks after initial dose, then 45–90 mg every 12 weeks </p></li>  </ul><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Discontinue if no response within 16 weeks</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP7790-stelara" style="margin: 0 0 0 20px;"><h1 class="title">Stelara® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10199">Janssen</a>)</span><span> <a title="Report adverse reaction(s)" href="PHP10518-yellow-card-scheme.htm"><img class="cD" src="images/blacktri_s.png" alt="Report adverse reaction(s)" /></a> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Injection</strong>, ustekinumab 90 mg/mL, net price 0.5-mL (45-mg) prefilled syringe = £2147.00. Label: 10, counselling, tuberculosis</p></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP7787-infliximab.htm">Previous: INFLIXIMAB</a> | <a class="top" href="PHP7790-stelara.htm#">Top</a> | <a accesskey="]" href="PHP7791-acne-and-rosacea.htm">Next: 13.6 Acne and rosacea</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>